403 related articles for article (PubMed ID: 31233118)
21. Patient-derived pancreatic tumour organoids identify therapeutic responses to oncolytic adenoviruses.
Raimondi G; Mato-Berciano A; Pascual-Sabater S; Rovira-Rigau M; Cuatrecasas M; Fondevila C; Sánchez-Cabús S; Begthel H; Boj SF; Clevers H; Fillat C
EBioMedicine; 2020 Jun; 56():102786. PubMed ID: 32460166
[TBL] [Abstract][Full Text] [Related]
22. Probing the tumorigenic potential of genetic interactions reconstituted in murine fallopian tube organoids.
Maru Y; Tanaka N; Tatsumi Y; Nakamura Y; Yao R; Noda T; Itami M; Hippo Y
J Pathol; 2021 Oct; 255(2):177-189. PubMed ID: 34184756
[TBL] [Abstract][Full Text] [Related]
23. CXCR2 signaling regulates KRAS(G¹²D)-induced autocrine growth of pancreatic cancer.
Purohit A; Varney M; Rachagani S; Ouellette MM; Batra SK; Singh RK
Oncotarget; 2016 Feb; 7(6):7280-96. PubMed ID: 26771140
[TBL] [Abstract][Full Text] [Related]
24. Zeb1 in Stromal Myofibroblasts Promotes
Sangrador I; Molero X; Campbell F; Franch-Expósito S; Rovira-Rigau M; Samper E; Domínguez-Fraile M; Fillat C; Castells A; Vaquero EC
Cancer Res; 2018 May; 78(10):2624-2637. PubMed ID: 29490942
[TBL] [Abstract][Full Text] [Related]
25. Genetics and Biology of Pancreatic Ductal Adenocarcinoma.
Dunne RF; Hezel AF
Hematol Oncol Clin North Am; 2015 Aug; 29(4):595-608. PubMed ID: 26226899
[TBL] [Abstract][Full Text] [Related]
26. Spheroid Culture of Human Pancreatic Ductal Cells to Reconstitute Development of Pancreatic Intraepithelial Neoplasia.
Lee JJ; Kim SK
Methods Mol Biol; 2019; 1882():63-71. PubMed ID: 30378044
[TBL] [Abstract][Full Text] [Related]
27. Tuft Cells Inhibit Pancreatic Tumorigenesis in Mice by Producing Prostaglandin D
DelGiorno KE; Chung CY; Vavinskaya V; Maurer HC; Novak SW; Lytle NK; Ma Z; Giraddi RR; Wang D; Fang L; Naeem RF; Andrade LR; Ali WH; Tseng H; Tsui C; Gubbala VB; Ridinger-Saison M; Ohmoto M; Erikson GA; O'Connor C; Shokhirev MN; Hah N; Urade Y; Matsumoto I; Kaech SM; Singh PK; Manor U; Olive KP; Wahl GM
Gastroenterology; 2020 Nov; 159(5):1866-1881.e8. PubMed ID: 32717220
[TBL] [Abstract][Full Text] [Related]
28. BRCA2 dysfunction promotes malignant transformation of pancreatic intraepithelial neoplasia.
Wang Q; Liu H; Liu T; Shu S; Jiang H; Cheng S; Yuan Y; Yang W; Wang L
Anticancer Agents Med Chem; 2013 Feb; 13(2):261-9. PubMed ID: 22934697
[TBL] [Abstract][Full Text] [Related]
29. Ductal obstruction promotes formation of preneoplastic lesions from the pancreatic ductal compartment.
Cheng T; Zhang Z; Jian Z; Raulefs S; Schlitter AM; Steiger K; Maeritz N; Zhao Y; Shen S; Zou X; Ceyhan GO; Friess H; Kleeff J; Michalski CW; Kong B
Int J Cancer; 2019 May; 144(10):2529-2538. PubMed ID: 30412288
[TBL] [Abstract][Full Text] [Related]
30. Deletion of Rb accelerates pancreatic carcinogenesis by oncogenic Kras and impairs senescence in premalignant lesions.
Carrière C; Gore AJ; Norris AM; Gunn JR; Young AL; Longnecker DS; Korc M
Gastroenterology; 2011 Sep; 141(3):1091-101. PubMed ID: 21699781
[TBL] [Abstract][Full Text] [Related]
31. Overall survival of pancreatic ductal adenocarcinoma is doubled by
Lee JS; Lee H; Woo SM; Jang H; Jeon Y; Kim HY; Song J; Lee WJ; Hong EK; Park SJ; Han SS; Kim SY
Theranostics; 2021; 11(7):3472-3488. PubMed ID: 33537098
[No Abstract] [Full Text] [Related]
32. Oxidative stress induced by inactivation of TP53INP1 cooperates with KrasG12D to initiate and promote pancreatic carcinogenesis in the murine pancreas.
Al Saati T; Clerc P; Hanoun N; Peuget S; Lulka H; Gigoux V; Capilla F; Béluchon B; Couvelard A; Selves J; Buscail L; Carrier A; Dusetti N; Dufresne M
Am J Pathol; 2013 Jun; 182(6):1996-2004. PubMed ID: 23578383
[TBL] [Abstract][Full Text] [Related]
33. Disruption of p16 and activation of Kras in pancreas increase ductal adenocarcinoma formation and metastasis in vivo.
Qiu W; Sahin F; Iacobuzio-Donahue CA; Garcia-Carracedo D; Wang WM; Kuo CY; Chen D; Arking DE; Lowy AM; Hruban RH; Remotti HE; Su GH
Oncotarget; 2011 Nov; 2(11):862-73. PubMed ID: 22113502
[TBL] [Abstract][Full Text] [Related]
34. LKB1 haploinsufficiency cooperates with Kras to promote pancreatic cancer through suppression of p21-dependent growth arrest.
Morton JP; Jamieson NB; Karim SA; Athineos D; Ridgway RA; Nixon C; McKay CJ; Carter R; Brunton VG; Frame MC; Ashworth A; Oien KA; Evans TR; Sansom OJ
Gastroenterology; 2010 Aug; 139(2):586-97, 597.e1-6. PubMed ID: 20452353
[TBL] [Abstract][Full Text] [Related]
35. IER3 supports KRASG12D-dependent pancreatic cancer development by sustaining ERK1/2 phosphorylation.
Garcia MN; Grasso D; Lopez-Millan MB; Hamidi T; Loncle C; Tomasini R; Lomberk G; Porteu F; Urrutia R; Iovanna JL
J Clin Invest; 2014 Nov; 124(11):4709-22. PubMed ID: 25250570
[TBL] [Abstract][Full Text] [Related]
36. Identification of susceptibility loci in a mouse model of KRASG12D-driven pancreatic cancer.
Jorgenson TC; Williams BR; Wendland A; Bilger A; Sandgren EP; Drinkwater NR
Cancer Res; 2010 Nov; 70(21):8398-406. PubMed ID: 20959479
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic effects of an anti-Myc drug on mouse pancreatic cancer.
Stellas D; Szabolcs M; Koul S; Li Z; Polyzos A; Anagnostopoulos C; Cournia Z; Tamvakopoulos C; Klinakis A; Efstratiadis A
J Natl Cancer Inst; 2014 Dec; 106(12):. PubMed ID: 25306215
[TBL] [Abstract][Full Text] [Related]
38. Bmi1 combines with oncogenic KRAS to induce malignant transformation of human pancreatic duct cells in vitro.
Chen SJ; Chen YT; Zeng LJ; Zhang QB; Lian GD; Li JJ; Yang KG; Huang CM; Li YQ; Chu ZH; Huang KH
Tumour Biol; 2016 Aug; 37(8):11299-309. PubMed ID: 26951514
[TBL] [Abstract][Full Text] [Related]
39. KRAS
Principe DR; Overgaard NH; Park AJ; Diaz AM; Torres C; McKinney R; Dorman MJ; Castellanos K; Schwind R; Dawson DW; Rana A; Maker A; Munshi HG; Rund LA; Grippo PJ; Schook LB
Sci Rep; 2018 Aug; 8(1):12548. PubMed ID: 30135483
[TBL] [Abstract][Full Text] [Related]
40. Molecular Characteristics of Pancreatic Ductal Adenocarcinomas with High-Grade Pancreatic Intraepithelial Neoplasia (PanIN) Are Different from Those without High-Grade PanIN.
Miyazaki T; Ohishi Y; Miyasaka Y; Oda Y; Aishima S; Ozono K; Abe A; Nagai E; Nakamura M; Oda Y
Pathobiology; 2017; 84(4):192-201. PubMed ID: 28291966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
